Skip to content
healthcare.dev
Get a free key

YESCARTA

NDC 71287-119, axicabtagene ciloleucel, suspension, from Kite Pharma, Inc..

Product NDC
71287-119
Status
Listed
Labeler
Kite Pharma, Inc.
Dosage form
SUSPENSION
Route
INTRAVENOUS
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125643
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71287-119 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AXICABTAGENE CILOLEUCEL2000000 1/68mL

Pharmacologic classes

CD19 Receptor Interactions [MoA]; CD19-directed Chimeric Antigen Receptor [EPC]; CD19-specific Chimeric Antigen Receptor [CS]; Genetically-modified Autologous T Cells [EPC]; Increased T Lymphocyte Activation [PE]; T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT]

Package NDCNDC-11Package
71287-119-02712870119021 BAG in 1 PACKAGE (71287-119-02) / 68 mL in 1 BAG (71287-119-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71287-119

Use it

Look up 71287-119 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71287-119 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71287-119. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.